Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sanofi
  6. News
  7. Summary
    SAN   FR0000120578

SANOFI

(SAN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SANOFI : Goldman Sachs reiterates its Buy rating

05/03/2021 | 05:21pm EDT

Keyur Parekh from Goldman Sachs retains his positive opinion on the stock with a Buy rating. The target price is increased from EUR 101 to EUR 105.


ę MarketScreener with dpa-AFX Analyser 2021
All news about SANOFI
11:19aEuropean ADRs Move Higher in Friday Trading
MT
12:20aGENOMIC VISIONá : Concludes First Part of Genetic Research Deal With Sanofi
MT
05/13GLAXOSMITHKLINEá : CureVac-GSK coronavirus variant vaccine generates good immune..
RE
05/13OROPHARYNGEAL CANCER PIPELINE : Emerging Therapies and Key pharma players involv..
AQ
05/13SANOFIá : Regeneron Cervical Cancer Drug Shown to Extend Lives in Late-Stage Stu..
MT
05/12REGENERON PHARMACEUTICALSá : Sanofi Report 'Positive' Libtayo Data From Phase 3 ..
MT
05/12SANOFIá : New data to be featured at EHA 2021 Congress highlight Sanofi's ongoin..
PU
05/12SANOFIá : 99.1. Information on Q1 2021 financial results (Form 6-K)
PU
05/12SECTOR UPDATE : Health Care Stocks Trade Lower Premarket Wednesday
MT
05/12CELLECTIS S Aá : Sanofi Agrees to Supply Alemtuzumab Antibody for Cellectis Tria..
MT
More news
Financials
Sales 2021 36 979 M 44 911 M 44 911 M
Net income 2021 5 929 M 7 201 M 7 201 M
Net Debt 2021 7 369 M 8 950 M 8 950 M
P/E ratio 2021 18,3x
Yield 2021 3,77%
Capitalization 108 B 132 B 132 B
EV / Sales 2021 3,13x
EV / Sales 2022 2,89x
Nbr of Employees 99 412
Free-Float 88,3%
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 101,28 €
Last Close Price 86,72 €
Spread / Highest target 34,9%
Spread / Average Target 16,8%
Spread / Lowest Target -13,5%
EPS Revisions
Managers and Directors
NameTitle
Paul Hudson Chief Executive Officer & Director
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President
Serge Weinberg Chairman
John C. Reed EVP & Global Head-Research & Development
Nestle Frank Global Head-Immunology Therapeutic Research Area
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI10.19%130 765
JOHNSON & JOHNSON8.16%447 572
ROCHE HOLDING AG-2.57%286 766
PFIZER, INC.8.94%223 684
ABBVIE INC.8.66%205 942
MERCK & CO., INC.-4.29%199 248